Aperion Biologics Receives CE Mark for Z-Lig ACLR Device

Aperion Biologics announced it has received CE Mark approval for its Z-Lig ACLR device.

Advertisement

The Z-Lig is the first engineered biologic device for treatment of revision and multiligament anterior cruciate ligament knee reconstruction to be granted a CE Mark.

 

Aperion Biologics is a privately owned, medical device company focused on addressing the need for alternatives to human-based grafts with animal-based tissue technology.

More Articles on Devices:

Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.